Table IV.
No. | Entry name | Peptide/glycopeptide sequence #1 | Peptide/glycopeptide sequence #2 | Peptide/glycopeptide sequence #3 |
---|---|---|---|---|
1 | APOE | ALMDET* MKELK | LRARMEEMGS* RT* R | S* WFEPLVEDMQRQWAGLVEK |
2 | MUC16 | TEALSLGRT* ST* PGPAQSTIS | DT* FNDSAAPQST* TWPETSPR | ISTSAPLSSS* AS* VLDNK |
3 | APP | LALENY* IT* ALQAVPPRPR | FLHQERMDVCETHLHWHT* VAKETCSEK | PAADRGLTTRa |
4 | AGRN | TTAAPTTRRPPT* T* APSRVPGR | TTAAPTTRRa | KDFRSVRa |
5 | CD44 | KPS* GLNGEAS* KS* QEMVHLVNK | SQEMVHLVNKa | RMDMDSSHSITLQPT* ANPNTGLVEDLDR |
6 | TGFB2 | LSSTWET* GK | EHPCVES* MK | IFPY* EEY* ASWKTEK |
7 | SLC2A12 | SS* LM** PLR | GCS* LEQISMELAKVNY* VKNNICFMSHHQEELVPK | Y*MFGLVIPLGVLQAIAMY FLPPS*PRFLVMKGQEGAASK |
8 | NID2 | KALEGLQY* PFAVT* SYGK | IEVAKLDGT* QR | IESALLDGSERa |
9 | CALU | MDLRQFLMCLSLCTAFALS* KPT* EK | IDGDKDGFVT* VDELKDWIK | TFDQLTPEESKERa |
10 | S1PR1 | YIT* MLK | IMS* CCK | T* CDILFR |
11 | MUC13 | HS* MAYQDLHSEITS* LFKDVF | CAFGY* S* GLDCKDK | STGFTNLGAEGSVFPKa |
12 | ITA5 | ERQVAT* AVQWT* K | HPGNFSS* LS* CDY* FAVNQSR | RSLPYGTAMEKa |
*GalNAc on serine, threonine or tyrosine;
**Oxidation on methionine;
aNot identified site-specific GalNAcylation